Cyrus S Poonawalla, chairman of Serum Institute of India, has created a legacy where business and social impact go hand in hand. His vaccin...

Serum Institute of India (SII) has announced its partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) network, based...

"Multilateral organisations such as the United Nations and the World Trade Organisation should take it upon themselves to harmonise the cer...

He was responding to Union Health Minister Mansukh Mandaviya's announcement that the Central Drug Authority, the Central Drugs Standard Con...

Serum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for restrict...

The deal with Serum Institute Life Sciences values Biocon Biologics at about $4.9 billion and will solely focus on COVID-19 vaccines in the...

Bharat Biotech on Saturday said it has priced Covaxin at ₹1,200 ($16) for the private market, while the Russian Development Investment Fund...

Apart from financial loss, the mishap will impact the production of BCG and Rotavirus vaccines, the company said in a statement.

The chief minister visited the SII on Friday to take stock of the damages. He later addressed a press conference, where Adar Poonawalla, Ch...

Serum Institute of India CEO Adar Poonawalla said the real challenge lies in taking the vaccine to the "common man, to the vulnerable group...

The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this...

The PM has said that India will make vaccines for all humanity and that is a commitment at the highest level, highly placed sources told ET...

Officials said both the Pfizer and the SII emergency use applications are being reviewed on an accelerated basis. But as the trials for Ser...

SII has already manufactured 40 million doses of the vaccine, under the at-risk manufacturing and stockpiling license from DCGI, the compan...

The investment amount will be treated as an advance and once the vaccine receives regulatory approvals, SII will include Bangladesh among t...

The company, privately owned by Cyrus Poonawalla and his son Adar Poonawalla, plans to float a special purpose vehicle (SPV) for its vaccin...

SII, Pune is currently one of the largest manufacturers of MMR group of vaccines and Pentavalent group of vaccines in the world, present in...